Fetma göder läkemedelsbolagen

from Börslunch · host EFN Ekonomikanalen

Börslunch tar sig i detta avsnitt an läkemedelssektorn. Tillsammans med gästerna Ellinor Hult, Health Invest och Johan Unnerus, Redeye analyseras Novo Nordisk, Bioarctic, Xvivo Perfusion, Calliditas, Camurus och Fusion Pharmaceuticals.

Episode metadata supplied by the publisher feed · Published Mar 18, 2024

Embed this episode

Attribution link and audio player

Ready to play

Fetma göder läkemedelsbolagen

0:00 23:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Börslunch?

This episode is 23 minutes long.

When was this Börslunch episode published?

This episode was published on March 18, 2024.

Can I download this Börslunch episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!